ACTIVE

Dr MATHIJS Zissi Endocrino-diabetologue

Financial year 2025 · Closed on 31/12/2025

Net result170,5 k €-17,7 %over 1 year
Gross margin284,3 k €-18,6 %over 1 year
Equity626,2 k €+31,6 %over 1 year

Identity

Source · BCE/KBO

Dr MATHIJS Zissi Endocrino-diabetologue is a Private limited company incorporated in 2011. Its main activity is: Specialist medical practice activities. Its registered office is in Le Roeulx.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0834.863.162
Incorporation
25/03/2011
Legal form
Private limited company
Registered office
Chaussée de Mons(R) 90
7070 Le Roeulx · WallonieSee on map
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 15 filings

Trend over 15 financial years

20252024202320222021
Income statement
Gross margin284,3 k €349,3 k €188,1 k €188,9 k €184,4 k €
EBITDA284,3 k €349,3 k €188,1 k €188,9 k €184,4 k €
Operating result251,1 k €321,9 k €169,5 k €171,1 k €166,1 k €
Net result170,5 k €207,3 k €124,1 k €115,6 k €112,3 k €
Balance sheet
Equity626,2 k €475,7 k €298,5 k €244,4 k €179,8 k €
Total assets779,6 k €708,3 k €438,1 k €400,8 k €337,9 k €
Cash156,5 k €83,7 k €18,8 k €236,2 k €158,5 k €
Debts153,4 k €232,5 k €139,6 k €156,4 k €158,2 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Zissi Mathijs
Mandate

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelMicro modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/04/202626/06/202515/07/202403/07/202315/07/202219/07/2021
General meeting04/04/202606/06/202507/06/202402/06/202330/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202504/04/202615/04/2026DutchPDF
Abridged model31/12/202406/06/202526/06/2025DutchPDF
Abridged model31/12/202307/06/202415/07/2024DutchPDF
Abridged model31/12/202202/06/202303/07/2023DutchPDF
Micro model31/12/202130/06/202215/07/2022DutchPDF
Abridged model31/12/202004/06/202119/07/2021DutchPDF
Abridged model31/12/201907/08/202001/09/2020DutchPDF
Abridged model31/12/201828/06/201924/08/2019DutchPDF
Abridged model31/12/201729/06/201820/08/2018DutchPDF
Abridged model31/12/201630/06/201724/07/2017DutchPDF
Abridged model31/12/201530/06/201623/08/2016DutchPDF
Abridged model31/12/201426/06/201524/07/2015DutchPDF
Abridged model31/12/201330/06/201424/07/2014DutchPDF
Abridged model31/12/201228/06/201321/08/2013DutchPDF
Abridged model31/12/201130/06/201230/08/2012DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Zissi Mathijs
Mandate

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office28/11/2013
    SIEGE SOCIAL
    PDF
  • Other29/03/2011
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings15 filings
2011201220132014201520162017201820192020202120222023202420252026
Dr MATHIJS Zissi Endocrino-diabetologue
Chaussée de Mons(R) 90, 7070 Le Roeulx
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Chaussée de Mons(R) 90, 7070 Le RoeulxCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00079601

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Dr MATHIJS Zissi Endocrino-diabetologueCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00079601

Events

  1. 2025
    Annual accounts 2025170,5 k €↓
  2. 2024
    Annual accounts 2024207,3 k €↑
  3. 2023
    Annual accounts 2023124,1 k €↑
  4. 2022
    Annual accounts 2022115,6 k €↑
  5. 2021
    Annual accounts 2021112,3 k €↑
  6. 2020
    Annual accounts 202056,4 k €↑
  7. 2019
    Annual accounts 201943,8 k €↑
  8. 2018
    Annual accounts 201835,4 k €↓
  9. 2017
    Annual accounts 201779,5 k €↓
  10. 2016
    Annual accounts 201683,9 k €↑
  11. 2015
    Annual accounts 201577,1 k €↓
  12. 2014
    Annual accounts 2014101,3 k €↓
  13. 2013
    Annual accounts 2013150,6 k €↑
  14. 2012
    Annual accounts 2012140,3 k €↑
  15. 2011
    Annual accounts 2011-15,4 k €
  16. 25/03/2011
    IncorporationPrivate limited company